15.09.2020 – 08:58 Stada ArzneimittelSTADA's US partner Supernus submits NDA for apomorphine infusion pump Press release STADA‘s US partner Supernus submits NDA for apomorphine infusion pump - STADA’s US commercial partner Supernus files New Drug Application (NDA) with US Food and Drug Administration for an apomorphine infusion pump (SPN-830). - The NDA filing for SPN-830 for continuous treatment of ... One documentmore
11.03.2019 – 14:35 seca gmbh & co. kg 5IHRSA 2019 - The world market leader seca turns body composition analysis into a business booster Click here One documentmore
